We are live on ! Find out more
EC

EntryPoint Capital Portfolio holdings

AUM $341M
1-Year Est. Return 20.57%
This Fund
S&P 500
This Quarter Est. Return
+8.02%
1 Year Est. Return
+20.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$176M
AUM Growth
+$107M
Cap. Flow
+$103M
Cap. Flow %
58.75%
Top 10 Hldgs %
4.24%
Holding
1,234
New
413
Increased
180
Reduced
1
Closed
640

Top Buys

Rank Stock Value
1
GH icon
Guardant Health
GH
+$895K
2
PLAB icon
Photronics
PLAB
+$774K
3
EW icon
Edwards Lifesciences
EW
+$755K
4
MMS icon
Maximus
MMS
+$754K
5
TTEK icon
Tetra Tech
TTEK
+$745K

Top Sells

Rank Stock Value
1
DK icon
Delek US
DK
+$197K
2
CSGP icon
CoStar Group
CSGP
+$197K
3
VIST icon
Vista Energy
VIST
+$197K
4
SKX
Skechers
SKX
+$196K
5
ALRS icon
Alerus Financial
ALRS
+$195K

Sector Composition

Rank Sector Weight
1 Healthcare 19.45%
2 Technology 17.59%
3 Industrials 17.43%
4 Consumer Discretionary 12.31%
5 Financials 10.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMSF icon
251
AMERISAFE
AMSF
$569M
$299K 0.17%
+6,194
New +$295K
BLBD icon
252
Blue Bird Corp
BLBD
$2.41B
$296K 0.17%
+6,164
New +$305K
DIOD icon
253
Diodes
DIOD
$4B
$295K 0.17%
+4,610
New +$319K
ABNB icon
254
Airbnb
ABNB
$83.7B
$294K 0.17%
+2,321
New +$301K
SCHL icon
255
Scholastic
SCHL
$796M
$294K 0.17%
+9,194
New +$294K
GPN icon
256
Global Payments
GPN
$22.1B
$294K 0.17%
+2,867
New +$298K
PGNY icon
257
Progyny
PGNY
$2.44B
$293K 0.17%
+17,498
New +$420K
ASTE icon
258
Astec Industries
ASTE
$1.3B
$293K 0.17%
+9,181
New +$295K
ORIC icon
259
Oric Pharmaceuticals
ORIC
$1.25B
$293K 0.17%
+28,580
New +$283K
ICHR icon
260
Ichor Holdings
ICHR
$3.02B
$291K 0.17%
+9,150
New +$296K
DVAX
261
DELISTED
Dynavax Technologies
DVAX
$291K 0.17%
+26,094
New +$288K
AMZN icon
262
Amazon
AMZN
$2.5T
$291K 0.17%
+1,560
New +$285K
PUBM icon
263
PubMatic
PUBM
$581M
$290K 0.17%
19,534
+13,618
+230% +$237K
PDD icon
264
Pinduoduo
PDD
$118B
$290K 0.17%
2,152
+1,610
+297% +$198K
LYEL icon
265
Lyell Immunopharma
LYEL
$309M
$287K 0.16%
+10,400
New +$306K
CVCO icon
266
Cavco Industries
CVCO
$4.39B
$287K 0.16%
+670
New +$264K
SMRT icon
267
SmartRent
SMRT
$183M
$286K 0.16%
+165,173
New +$314K
WABC icon
268
Westamerica Bancorp
WABC
$1.39B
$285K 0.16%
5,776
+5,546
+2,411% +$282K
RPC
269
Ridgepost Capital
RPC
$927M
$285K 0.16%
+26,594
New +$261K
DCOM icon
270
Dime Commercial Bancshares
DCOM
$1.75B
$285K 0.16%
+9,880
New +$240K
NDAQ icon
271
Nasdaq
NDAQ
$51.5B
$283K 0.16%
3,880
+2,771
+250% +$189K
CSW
272
CSW Industrials
CSW
$4.71B
$283K 0.16%
773
+156
+25% +$48.7K
CHCT
273
Community Healthcare Trust
CHCT
$537M
$283K 0.16%
15,593
+8,756
+128% +$179K
CTKB icon
274
Cytek Biosciences
CTKB
$576M
$283K 0.16%
+51,030
New +$289K
KALV
275
DELISTED
KalVista Pharmaceuticals
KALV
$282K 0.16%
24,322
+20,792
+589% +$262K
9 10
11
12 13

Similar funds

SFA
Seneca Financial Advisors Rochester, New York $341M AUM 14.73% 1-Year Est. Return
FCM
Findell Capital Management New York $341M AUM 135.6% 1-Year Est. Return
CPI
Crestview Partners II New York $341M AUM 17.29% 1-Year Est. Return
SW
SMART Wealth Omaha, Nebraska $341M AUM 24.37% 1-Year Est. Return
MTIC
Missouri Trust & Investment Company Springfield, Missouri $341M AUM 17.31% 1-Year Est. Return
KFSC
Keystone Financial Services (Colorado) Loveland, Colorado $341M AUM 18.11% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
SC
Slotnik Capital Dallas, Texas $342M AUM 105.92% 1-Year Est. Return

EntryPoint Capital's Q3 2024 Portfolio in Review

As of Q3 2024, EntryPoint Capital held 1,234 positions worth $176M, up 157% from $68.4M the previous quarter. Its ten largest holdings account for 4.2% of the portfolio.

EntryPoint Capital deployed $103M of net new capital in Q3 2024, opening 413 new positions and adding to 180 existing holdings. Its largest new stake was Guardant Health: 31,633 shares worth $726K.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iRadimed, an estimated $8.4K trimmed.

  • EntryPoint Capital's largest Q3 2024 buy was Guardant Health: 31,633 shares worth $726K.
  • EntryPoint Capital added most to Edwards Lifesciences in Q3 2024, an estimated $755K increase.
  • EntryPoint Capital's biggest Q3 2024 reduction was iRadimed, cutting an estimated $8.4K.
  • EntryPoint Capital fully exited Delek US in Q3 2024, selling an estimated $197K.
  • EntryPoint Capital's ten largest holdings make up 4.2% of its $176M portfolio in Q3 2024.
  • EntryPoint Capital opened 413 new positions and closed 640 in Q3 2024.
  • EntryPoint Capital's portfolio value rose 157% quarter-over-quarter to $176M.

Based on EntryPoint Capital's 13F filing for Q3 2024, filed 13 Nov 2024.